Akers Biosciences, Inc.

About Akers Biosciences, Inc.

Akers Biosciences (NASDAQ: AKER) develops, manufactures, and supplies rapid, point of care screening and testing products designed to bring health-related information directly to the patient or clinician in a timely and cost-efficient manner. In addition, the company is pursuing the development of a newly acquired license to a coronavirus vaccine candidate.

News Feed